Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Lung Cancer
Mental Health
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
LUNG CANCER
December 16, 2020
New Dosing Option Approved for Durvalumab in NSCLC
December 16, 2020
Irinotecan Liposome Injection Fast-Tracked for SCLC
November 17, 2020
Lorlatinib Effective for Advanced Anaplastic Lymphoma Kinase–Positive NSCLC
November 17, 2020
Some Common Drugs May Reduce Lung Cancer Mortality
November 17, 2020
FDA Approves Pralsetinib for Metastatic RET Fusion-Positive NSCLC
October 19, 2020
Study Shows Efficacy of Selpercatinib in RET Fusion–Positive NSCLC
October 19, 2020
FDA Grants Priority Review of Trilaciclib for Treating Small Cell Lung Cancer
October 19, 2020
NDA Accepted for Tepotinib Against Metastatic Non-Small Cell Lung Cancer
May 27, 2020
One-Tenth of CVD, Cancer, and Infectious Disease Patients Are Misdiagnosed
April 22, 2020
Polypharmacy Heightens Postchemotherapy Hospitalization Risk
September 12, 2019
Pembrolizumab Indication for Small-Cell Lung Cancer?
June 12, 2019
Use of Inhaled Steroids Linked to Reduced Lung-Cancer Risks in COPD Patients
April 10, 2019
Preventive Drugs Continued at End of Life Have Many Unnecessary Costs
Load More
X
January 2021
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image